Stock 000597 NORTHEAST PHARMACEUTICAL GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Northeast Pharmaceutical Group Co., Ltd.

Equities

000597

CNE0000009G0

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
4.75 CNY +1.93% Intraday chart for Northeast Pharmaceutical Group Co., Ltd. +1.50% -11.21%
Apr. 25 Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 01 Northeast Pharmaceutical Group Co., Ltd. Proposes Profit Distribution for 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Northeast Pharmaceutical Group Co., Ltd. Proposes Profit Distribution for 2023
CI
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Northeast Pharmaceutical's Levocarnitine Gets Nod to Enter EU Market
MT
Northeast Pharmaceutical's Piracetam Passes Generic Drug Evaluation in China
MT
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Northeast Pharmaceutical to Set Up Joint Venture With Muscat Changming Investments in Oman
MT
Northeast Pharmaceutical Group Co., Ltd.(XSEC:000597) added to S&P Global BMI Index
CI
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Northeast Pharmaceutical Group Co., Ltd. Announces 2022 Final Cash Profit Distribution Plan, Payable on 16 May 2023
CI
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Northeast Pharmaceutical Group Co., Ltd. Approves Final Cash Dividend for 2022
CI
Northeast Pharmaceutical Group Co., Ltd. Proposes Final Cash Dividend for 2022
CI
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
China Monthly Antitrust Update - March 2023
AQ
Northeast Pharma Appoints Former Bank Auditor as CFO
MT
Northeast Pharmaceutical Unit Registers Anti-Seizure Drug in China
MT
Northeast Pharmaceutical’s Piracetam Tablets Gets Regulatory Approval
MT
Northeast Pharmaceutical Gets Supplementary Drug Application Approval For Tinidazole Tablets
MT
Northeast Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 000597 Stock
  4. News Northeast Pharmaceutical Group Co., Ltd.